Search for: "By Andrew Pollack"
Results 61 - 80
of 86
Sort by Relevance
|
Sort by Date
31 Mar 2010, 7:04 am
While the immediate impact will likely be muted until an appellate court weighs in on the issue, NYT reporter Andrew Pollack writes that “the invalidation of genetic patents could hit diagnostics companies, agricultural biotechnology companies and perhaps even traditional drug makers. [read post]
30 Mar 2010, 6:01 am
That said, the NYT’s John Schwartz and Andrew Pollack note that the ruling, if upheld, “could throw into doubt the patents covering thousands of human genes and reshape the law of intellectual property. [read post]
15 Jan 2010, 11:18 am
Kennedy, Jr to Linda Fairstein to Eliot Spitzer to Andrew Cuomo. [read post]
5 Nov 2009, 12:13 pm
Andrew Pollack has a story on the New York Times' website that reports "[a]s many as 25 percent of the American farmers growing genetically engineered corn are no longer complying with federal rules intended to maintain the resistance of the crops to damage from insects, according to an advocacy group's report released Thursday. [read post]
28 Oct 2009, 2:45 pm
"Reporter Andrew Pollack wrote that only 4 of the 14 disease team projects approved by CIRM today involve embryonic stem cells. [read post]
23 Sep 2009, 5:30 am
"According to Andrew Pollack's story for the New York Times, this decision could open the door for a ban on the beets that are planted on roughly 1.1 million acres of American farms. [read post]
2 Sep 2009, 9:59 pm
Written by Andrew Pollack, one of the paper's senior business and technology writers, the article highlights the interplay between scientific interest and business opportunity driving this phenomenon. [read post]
2 Jun 2009, 8:03 am
As reported by Andrew Pollack in the New York Times, the new study was presented at the annual meeting of the American Society of Clinical Oncology. [read post]
1 May 2009, 12:59 am
Andrew's School in Richmond received more than 70 new and used books. [read post]
10 Mar 2009, 1:21 pm
" Pollack discussed the [read post]
6 Mar 2009, 9:39 am
Analysts said the new price was likely to entice many more Genentech shareholders to tender their shares, The New York Times's Andrew Pollack reports. [read post]
24 Feb 2009, 7:47 am
Last week, Andrew Pollack of the New York Times reported on a statement submitted to the Environmental Protection Agency by a group of 26 scientists engaged in biotechnology crop research. [read post]
21 Feb 2009, 9:55 pm
Andrew Pollack in the NYT has a piece titled Crop Scientists Say Biotechnology Seed Companies Are Thwarting Research which includes the text:"No truly independent research can be legally conducted on many critical questions," the scientists wrote in a statement submitted to the Environmental Protection Agency. [read post]
7 Oct 2008, 12:00 pm
But a more fundamental issue is that hundreds, if not thousands, of diseases are probably genetically mediated.In an article in the May 6, 2008, New York Times, Andrew Pollack has a great map, called the Diseasome, of some of the diseases believed to be genetically mediated, and the probable number of genes in which changes have to occur, in order to produce the disease. [read post]
5 Jun 2008, 4:40 am
As reported by Andrew Pollack in The New... [read post]
7 May 2008, 6:34 pm
NY Times: California Awards $271 Million for Stem Cell Research, by Andrew Pollack: California has awarded $271 million in grants to build 12 new stem cell research centers in the state, even as one of the political rationales for the... [read post]
26 Oct 2007, 2:50 am
Andrew Pollack, The New York Times 10/12/2007 Read Article: The New York Times [read post]
8 Sep 2007, 9:01 pm
Al Qaeda in Iraq, which didn't even exist on 9/11, may represent as little as 2 to 5 percent of the Sunni insurgency, according to a new investigation in The Washington Monthly by Andrew Tilghman, a former Iraq correspondent for Stars and Stripes. . . . [read post]
29 Jun 2007, 1:13 am
Dean, Center for Appellate Litigation, New York (Gayle Pollack of counsel), for appellant. [read post]
12 May 2007, 4:27 pm
Panel Seeks Limits on Cancer Patient Drugs, by Andrew Pollack. [read post]
